Biomed Diagnostics' VTM-C19 Transit Tube is intended for on-site collection and transport to the testing laboratory of human clinical specimens containing SARS-CoV-2 — the virus that causes COVID-19 disease in humans and/or (USA only) influenza A virus. 1–4
Intended to be inoculated with specimens collected with a nasopharyngeal (NP) or oropharyngeal (OP) synthetic fiber swab (not provided), VTM-C19 has been validated to transport SARS-CoV-2 and (USA only) influenza A viral specimen appropriately to the lab for analysis with qRT-PCR.
• VTM-C19 Transit Tubes ensures a non-replicating competent status of SARS-CoV-2 (COVID-19) and (USA only) influenza A.
• Safe transport and preservation of the specimen
• Do not freeze the VTM-C19 Transit Tube.
Do not freeze the VTM-C19 Transit Tube. Upon receipt, store at 2-8°C, and keep away from direct light exposure. Do not use a tube if it appears to be damaged, leaking or the media appears to be cloudy.
After receipt or removal from refrigerated temperature (2-8°C), the VTM-C19 Transit Tube can be stored at room temperature (18-25°C) for up to 90 days without deterioration of performance, but not past the expiration date on the tube.
The VTM-C19 Transit Tube is designed for safe transport. Inoculated tubes should be transported within 72 hours after inoculation and maintained at 2-8°C. 2
For In Vitro Diagnostic Use.
Not available in all countries; please inquire.
CE IVD marked for use with SARS-CoV-2 testing
The VTM-C19 Transit Tube is available for use in the USA under the FDA guidance “Enforcement Policy for Viral Transport Media During the Coronavirus Disease 2019 (COVID-19) Public Health Emergency” (July 2020). The VTM-C19 Transit Tube has completed the Notification process. The VTM-C19 Transit Tube is available for use in the USA with FDA-cleared molecular influenza tests as described in the FDA guidance “Enforcement Policy for Modifications to FDA-Cleared Molecular Influenza and RSV Tests During the Coronavirus Disease 2019 (COVID-19) Public Health Emergency” (October 2020).4